Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Evoke Pharma (EVOK) Asset Utilization Ratio (2020 - 2025)

Historic Asset Utilization Ratio for Evoke Pharma (EVOK) over the last 6 years, with Q3 2025 value amounting to 0.91.

  • Evoke Pharma's Asset Utilization Ratio rose 3878.47% to 0.91 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.91, marking a year-over-year increase of 3878.47%. This contributed to the annual value of 0.83 for FY2024, which is 5223.8% up from last year.
  • As of Q3 2025, Evoke Pharma's Asset Utilization Ratio stood at 0.91, which was up 3878.47% from 0.79 recorded in Q2 2025.
  • In the past 5 years, Evoke Pharma's Asset Utilization Ratio registered a high of 0.91 during Q3 2025, and its lowest value of 0.0 during Q1 2021.
  • Its 5-year average for Asset Utilization Ratio is 0.41, with a median of 0.38 in 2023.
  • Its Asset Utilization Ratio has fluctuated over the past 5 years, first surged by 1273727.61% in 2022, then crashed by 679.35% in 2024.
  • Over the past 5 years, Evoke Pharma's Asset Utilization Ratio (Quarter) stood at 0.15 in 2021, then surged by 36.39% to 0.2 in 2022, then soared by 249.62% to 0.69 in 2023, then decreased by 6.79% to 0.65 in 2024, then soared by 40.57% to 0.91 in 2025.
  • Its Asset Utilization Ratio stands at 0.91 for Q3 2025, versus 0.79 for Q2 2025 and 0.68 for Q1 2025.